[Relationship between serum IL-8 hsCRP, TNF-α and coronary lesions in CHD patients]

Jin-guang Luo1

  • 1Cardiology of Anyang People's Hospital in Henan Province, Anyang, China.

Insights

Serum interleukin-8 (IL-8), high-sensitivity C-reaction protein (hsCRP), and tumor necrosis factor-α (TNF-α) are elevated in coronary heart disease (CHD) patients. Higher levels of these inflammation markers correlate with the severity of coronary lesions.

Area of Science:

  • Cardiovascular Medicine
  • Immunology
  • Biochemistry

Context:

  • Coronary heart disease (CHD) is a leading cause of mortality worldwide.
  • Inflammation plays a critical role in the pathogenesis and progression of atherosclerosis.
  • Specific inflammatory markers may serve as indicators of disease severity.

Purpose:

  • To investigate the association between serum levels of interleukin-8 (IL-8), high-sensitivity C-reaction protein (hsCRP), and tumor necrosis factor-α (TNF-α) and the extent of coronary artery lesions in patients with CHD.
  • To determine if these inflammatory markers correlate with the severity of coronary lesions as quantified by the Gensini score.

Summary:

  • This study compared serum IL-8, hsCRP, and TNF-α levels in 106 CHD patients and 100 healthy controls.
  • CHD patients exhibited significantly higher levels of all three inflammatory markers compared to controls (P < 0.05).
  • Serum levels of IL-8, hsCRP, and TNF-α demonstrated a positive correlation with the Gensini score, indicating a relationship between inflammation and lesion severity (P < 0.05).

Impact:

  • Findings suggest that elevated serum IL-8, hsCRP, and TNF-α are associated with increased coronary lesion severity in CHD patients.
  • These inflammatory markers could potentially serve as biomarkers for assessing disease progression and risk stratification in CHD.
  • Further research may explore therapeutic strategies targeting these inflammatory pathways to manage CHD.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...